AVHEC 2019
AVHEC 2019

Poster Listing

Click on the presentation name to view the PDF poster

Poster number Presenter Presentation Abstract
1 Sandy Davidson ADDRESSING STIGMA ASSOCIATED WITH HEPATITIS B AMONG CHINESE AND KOREAN AUSTRALIANS: FAMILY HEALTH AND CANCER PREVENTION Abstract
2 Sandy Davidson LET'S STICK TOGETHER TO CLOSE THE GAP Abstract
3 Sha Liu IS SPEAKING THE SAME LANGUAGE GOOD ENOUGH? LESSONS LEARNT FROM WORKING WITH THE CHINESE COMMUNITY Abstract
4 Sambath My MULTIPLE APROACHES TO AWARENESS ON VIRAL HEPATITIS B AND THE AVAILABILITY OF FREE VACCINE AMOUNG THE CAMBODIAN COMMUNITY IN SOUTH EAST MELBOURNE Abstract
5 Sonam Paljor CHALLENGING CULTURAL ASSUMPTIONS BEYOND VIRAL HEPATITIS ELIMINATION: THE DIVERSITY HUB EXPERIENCE Abstract
6 Evelyn Pe SUPPORTING PEOPLE LIVING WITH CHRONIC HEPATITISB (CHB) IN THE MYANNMER COMMUNITY Abstract
7 Aurora Tang FROM PARTNERSHIP TO LEADERSHIP: VICTORIAN CHINESE COMMUNITY MOBILISE TO ELIMINATE HEPATITIS B Abstract
8 Nicole Allard EVALUATING THE COVERAGE OF HEPATITIS B WORKFORCE DEVELOPMENT IN PRIMARY CARE Abstract
9 Tanya Applegate EVALUATION OF HCV RNA TESTING FROM FINGER-STICK CAPILLARY DRIED BLOOD SPOT AND VENEPUNTURE-COLLECTED SAMPLES: A COHORT STUDY Abstract
10 David Baker NEVER FEAR- POLAR IS HERE; A NATIONALLY AVAILABLE TOOL FOR CHRONIC HEPATITIS B MANAGEMENT IN GENERAL PRACTICE Abstract
11 Sofia Bartlett HEPATITIS C VIRUS TREATMENT UPTAKE DIFFERS ACCORDING TO RECENCY OF OPIOID AGONIST THERAPY AMONG PEOPLE WHO INJECT DRUGS WITH CHRONIC HEPATITIS C INFECTION Abstract
12 Marian Bloomfield DRIED BLOOD SPOT FOR HIV AND HCV – TESTING PRIORITY POPULATION GROUPS IN THE NSW CUSTODIAL SETTING Abstract
13 Samantha Bolton HEPATITIS C TREATMENT IN PRISON: A FORUM FOR QUEENSLAND Abstract
14 Rebecca Bowman ****WITHDRAWN****RESISTANCE, REINFECTION OR RELAPSE: A CASE STUDY
15 Lauren Bradley CUSTODIAL SETTINGS: THE MISSING LINK TO HEPATITIS C ELMINATION Abstract
16 Susan Campfield COMMUNITY-BASED MODEL OF CARE FOR HEPATITIS C TREATMENT Abstract
17 Marilou Capati EPIDEMIOLOGY OF CHRONIC HEPATITIS B IN A BULK-BILLING GP CLINIC IN DARWIN Abstract
18 Heidi Coupland "I'LL HAVE HEP C TREATMENT EVENTUALLY": SHEDDING LIGHT ON WHAT IT TAKES TO INCREASE HEPATITIS C TREATMENT UPTAKE WHEN CLIENTS HAVE OTHER PRIORITIES Abstract
19 Evan Cunningham REINFECTION FOLLOWING SUCCESSFUL HCV DAA THERAPY AMONG PEOPLE WITH RECENT INJECTING DRUG USE OR CURRENT OPIOID SUBSTITUTION THERAPY Abstract
20 Olivia Dawson HEPATITIS C EDUCATION FOR NSP FRONTLINE WORKERS: PRELIMINARY EVALUATION FINDINGS FROM A NATIONAL CAPACITY STRENGTHENING PROGRAM Abstract
21 Julie-Anne Downie HEP C PROJECT INREACH 'SAME SAME BUT DIFFERENT SETTING’ Abstract
22 N/A N/A
23 Marley Easterbrook OPEN-ACCESS HBV RESEARCH PROTOCOL DATABASE Abstract
24 Annette Fraser THE ONE PHONE CALL AT A TIME APPROACH TO ELIMINATING HEPATITIS C IN THE WESTERN AUSTRALIAN COMMUNITY Abstract
25 Louise Geddes SEX DISCREPANCIES IN THE PROTECTIVE EFFECT OF OPIOID AGONIST THERAPY ON INCIDENT HEPATITIS C INFECTION Abstract
26 Jason Grebely HCV REINFECTION AND INJECTING RISK BEHAVIOR FOLLOWING ELBASVIR/GRAZOPREVIR TREATMENT IN PATIENTS ON OPIOD AGONIST THERAPY: CO-STAR PART B Abstract
27 Brendan Harney A NURSE-LED, COMMUNITY BASED MODEL OF HEPATITIS C CARE IN MELBOURNE, AUSTRALIA; 2017-2018 Abstract
28 Brendan Harney HEPATITIS B IMMUNITY AND SUSCEPTABILITY AMONG PEOPLE LIVING WITH HIV AND HEPATITIS C CO-INFECTION IN MELBOURNE, AUSTRALIA Abstract
29 Sichan He EFFECTIVENESS OF DIRECT-ACTING ANTIVIRAL TREATMENT FOR HEPATITIS C AMONG PEOPLE WITH HEPATOCELLULAR CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS Abstract
30 Jo Holden DRIED BLOOD SPOT (DBS) TESTING PILOT Abstract
31 Dianne How Chow HEPATITIS C SPECIALIST NURSES USE NOTIFICATION DATA TO ENHANCE ENGAGEMENT WITH AND EDUCATION OF GENERAL PRACTITIONERS IN SOUTH EASTERN SYDNEY Abstract
32 Dianne How Chow ICHAT. EVALUATION OF AN INNOVATIVE NURSE LED PRIMARY HEALTH MODEL OF CARE FOR PATIENTS WITH HEPATITIS C IN INNER CITY SYDNEY Abstract
33 Behzad Hajari UPTAKE OF HEPATITIS C DIRECT-ACTING ANTIVIRAL TREATMENT AMONG INDIVIDUALS WITH HIV CO-INFECTION IN AUSTRALIA Abstract
34 Hayden Jose IMPROVED HEPATITIS B TESTING AND MANAGEMENT AMONG GPS THAT HAVE COMPLETED S100 HEPATITIS B COMMUNITY PRESCRIBER PROGRAM TRAINING Abstract
35 Shelley Kerr REMOVING BARRIERS: AN ONLINE LEARNING MODULE FOR NURSES TO ELIMINATE STIGMA AND DISCRIMINATION TOWARDS PEOPLE LIVING WITH BLOOD-BORNE VIRUSES Abstract
36 Chloe Layton SUPPORTING PRIMARY CARE CLINICS TO PRIORITISE HEPATITIS C TESTING AND TREATMENT – THE EC NURSE-LED MODEL Abstract
37 Kyle Leadbeatter THE VALUE OF A PEER AND CLINICAL PARTNERSHIP TO FACILITATE HEPATITIS C HEALTHCARE ACCESS IN PRIORITY SETTINGS Abstract
38 Caroline Lee ADHERENCE AND VIROLOGICAL OUTCOMES OF HEPATITIS B ANTIVIRAL THERAPY AMONGST INDIGENOUS AND NON-INDIGENOUS PATIENTS IN THE REMOTE TOP END, NORTHERN TERRITORY Abstract
39 Alison Marshall BARRIERS AND FACILITATORS TO ENGAGING IN HCV MANAGEMENT AND DAA THERAPY AMONG GENERAL PRACTITIONERS AND DRUG AND AND ALCOHOL SPECIALISTS - THE PRACTITIONER EXPERIENCE Abstract
40 Colette Mcgrath HEPATITIS IN PRISONS ELIMINATION (HIPE) PROGRAM, PHASE ONE: OUTCOMES AND LESSONS LEARNED Abstract
41 Kerrie Mckenzie OPPORTUNISTIC ENGAGEMENT THROUGH NSPs IN A COMMUNITY SETTING Abstract
42 Winnie Nguyen ENHANCING HCV TREATMENT IN THE TRANSITION SPACE: HEPATITIS C PROBATION AND PAROLE PILOT IN SOUTH EAST QUEENSLAND Abstract
43 Mim O'Flynn TOWARDS A CURE ON THE INSIDE Abstract
44 Joss O'loan HCV IN THE AUSTRALIAN PRIMARY CARE SETTING: REAL WORLD EFFECTIVENESS OF 12 WEEKS OF SOFOSBUVIR/VELPATASVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C Abstract
45 Julie Page INDOCTRINATION –UPSKILLING DOCTORS IN REAL WORLD SETTINGS Abstract
46 Anup John Pereira A LEAP IN THE RIGHT DIRECTION- DEBUNKING MYTHS, SOLIDIFYING ENGAGEMENT AND TRANSFORMING HEALTH ATTITUDES WITHIN CANBERRA’S MULTICULTURAL SETTINGS Abstract
47 Meg Perrier HEPATITIS B ADULT MIGRANT EDUCATION; MOVING TOWARDS A SUSTAINABLE SPACE Abstract
48 Jeffrey Post OPPORTUNISTIC ASSESSMENT AND TREATMENT OF PEOPLE WITH HEPATITIS C VIRUS INFECTION ADMITTED TO HOSPITAL FOR OTHER REASONS: A PROSPECTIVE COHORT STUDY Abstract
49 Jeffrey Post SAFETY, EFFECTIVENESS AND POTENTIAL CONTIBUTION TO HEPATITIS C VIRUS (HCV) ELIMINATION OF A PRISON-BASED NURSE-LED HCV TREATMENT PROGRAM IN NSW, AUSTRALIA Abstract
50 Darren Russell SO YOUR PRISON IS HEP C FREE – NOW WHAT? Abstract
51 Darren Russell ON THE ROAD TO MAKING 'CAIRNS HEP C FREE BY 2020' - ARE WE THERE YET? Abstract
52 N/A N/A
53 Nick Scott A GLOBAL INVESTMENT CASE FOR HEPATITIS C Abstract
54 Linda Selvey ***WITHDRAWN*** PERSONAL, PROVIDER AND SYSTEM LEVEL BARRIERS AND ENABLERS FOR HCV DAA TREATMENT IN GENERAL PRACTICE SETTINGS
55 Christine Selvey USE OF ROUTINE HEPATITS NOTIFICATION DATA TO SUPPORT DAA TREATMENT UPTAKE IN NEW SOUTH WALES Abstract
56 Sarah Smith HEPATITIS B POP-UP SCREENING AT UNSW - WAS IT ALL WORTH IT? Abstract
57 Sarah Smith HEPATITIS B COMMUNITY OUTREACH TESTING - SUCCESS THROUGH COLLABORATION Abstract
58 Sarah Smith TURNING OUTWARD: USING COMMUNITY CONVERSATIONS WITH PEOPLE WHO INJECT DRUGS IN SOUTHERN SYDNEY TO UNDERSTAND THE FACTORS INFLUENCING THEIR HEALTH AND WELLBEING Abstract
59 Azriel Tan SUB-OPTIMAL PATTERNS OF HCV TESTING IN HOSPITALISED PEOPLE WHO INJECT DRUGS: A MISSED OPPORTUNITY? Abstract
60 Alex Thompson GLOBAL REAL WORLD EVIDENCE OF SOFOSBUVIR/VELPATASVIR AS A SIMPLE, EFFECTIVE REGIMEN FOR THE TREATMENT OF CHRONIC HEPATITIS C PATIENTS: INTEGRATED ANALYSIS OF 12 CLINICAL PRACTICE COHORTS Abstract
61 Danika Tremain ***WITHDRAWN***DRIED BLOOD SPOT TESTING IN DRUG AND ALCOHOL CLINICAL SERVICES: A PILOT STUDY
62 Heather Valerio UPTAKE OF TESTING, LINKAGE TO CARE, AND TREATMENT FOR HEPATITIS C INFECTION AMONG PEOPLE WHO INJECT DRUGS IN AUSTRALIA: THE ETHOS ENGAGE STUDY Abstract
63 Samantha White BE LIVER SMART PROJECT Abstract
64 Yinzong Xiao SYSTEMATIC REVIEW OF METHODS FOR THE SURVEILLANCE OF HEPATITIS B VIRUS IN LOW PREVALENCE COUNTRIES, 2017 Abstract
65 Matthew Young THE KOMBI CLINIC – IT’S THE END OF THE ROAD FOR HEPATITIS C Abstract
66 Sahar Bajis HEPATITIS C VIRUS TESTING, LIVER DISEASE ASSESSMENT AND TREATMENT UPTAKE AMONG PEOPLE WHO INJECT DRUGS PRE- AND POST-UNIVERSAL ACCESS TO DIRECT-ACTING ANTIVIRAL TREATMENT IN AUSTRALIA: THE LIVERLIFE Abstract
67 Anne Balcomb AUSTRALIAN RURAL PRIMARY CARE LED VIRAL HEPATITIS CLINIC - OUTCOME DATA FROM 3 YEARS OF DIRECT ACTING ANTIVIRAL AGENTS (DAA'S) Abstract
68 Bridget Draper COMMUNITY-BASED POINT-OF-CARE TESTING AND TREATMENT FOR PEOPLE WHO INJECT DRUGS AND GENERAL POPULATION IN MYANMAR Abstract
69 Ingrid Francis COLLABORATIVE APPROACH TO THE MANAGEMENT OF HEPATITIS C AT NUMINBAH QUEENSLAND CORRECTIONAL FACILITY Abstract
70 Peta Gava NOTHING ABOUT US WITHOUT US: THE ROLE OF PEER EDUCATORS IN HCV TESTING AND TREATMENT UPTAKE Abstract
71 Jake Williams UNIVERSAL BLOOD-BORNE VIRUS SCREENING IN PATIENTS WITH SEVERE MENTAL ILLNESS MANAGED IN AN OUTPATIENT CLOZAPINE CLINIC: UPTAKE AND PREVALENCEY Abstract
72 Alisa Pedrana HEPATITIS C ANTIBODY TESTING TREND PRE AND POST UNIVERSAL ACCESS TO DIRECT ACTING ANTIVIRALS IN AUSTRALIA: SEGMENTED REGRESSION OF PRIMARY CARE CLINIC DATA Abstract
73 Alisa Pedrana A GLOBAL INVESTMENT FRAMEWORK FOR HEPATITIS C ELIMINATION Abstract
74 Alisa Pedrana KNOWLEDGE OF HEPATITIS C TESTING AND TREATMENT GUIDELINES AMONG PEOPLE AT RISK OF, OR LIVING WITH, HEPATITIS C. Abstract
75 Alisa Pedrana TAILORING HEPATITIS C HEALTH PROMOTION FOR PEOPLE WHO INJECT DRUGS Abstract
76 Neil Arvin Bretana A COMBINED TREATMENT AND PREVENTION APPROACH IS VITAL IN ELIMINATING HEPATITIS C VIRUS IN AUSTRALIAN PRISONS: A MODELLING STUDY Abstract
77 Jennifer MacLachlan EPIDEMIOLOGY OF CHRONIC HEPATITIS B AND C IN VICTORIA: INSIGHTS AND IMPACTS FROM ENHANCED SURVEILLANCE Abstract
78 Anna Palmer A COST-EFFECTIVENESS ANALYSIS OF PRIMARY VERSUS HOSPITAL-BASED SPECIALIST CARE FOR DIRECT ACTING ANTIVIRAL HEPATITIS C TREATMENT Abstract
79 Jasmine Yee HIGH EFFICACY OF DIRECT-ACTING ANTIVIRAL THERAPY FOR CHRONIC HCV IN AN AUSTRALIAN REAL-WORLD COHORT: THE REACH-C STUDY Abstract
80 Rosie Gilliver ACCESSING HIDDEN POPULATIONS: AN EXTENDED OUTREACH SERVICE OF THE KIRKETON ROAD CENTRE Abstract
81 Phillip Read PARTNERING WITH CONSUMERS: THE DEVELOPMENT OF A PRIMARY HEALTH CARE HEPATITIS C TREATMENT MODEL WITHIN A PEER-BASED NEEDLE AND SYRINGE PROGRAM Abstract
82 Phillip Read WHEN TREATMENT ACCESS DOES NOT EQUAL TREATMENT INITIATION: AN ANALYSIS OF CLIENTS WHO DO NOT INITIATE DIRECT ACTING ANTIVIRALS Abstract